Alessandra Ferrajoli, MD, Professor

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Abbvie
    Topic:
    Venetoclax
    Date added:
    12/14/2023
    Date updated:
    12/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astra-Zeneca
    Topic:
    Acalabrutinib
    Date added:
    12/14/2023
    Date updated:
    12/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Beigene
    Topic:
    Zanubrutinib
    Date added:
    12/14/2023
    Date updated:
    12/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Johnson & Johnson
    Topic:
    ibrutinib
    Date added:
    12/14/2023
    Date updated:
    12/14/2023
Return to BTF Best of ASH and SABCS 2024, Houston